Literature DB >> 18534710

MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.

Claire Z Larter1, Matthew M Yeh, Jacqueline Williams, Kim S Bell-Anderson, Geoffrey C Farrell.   

Abstract

BACKGROUND/AIMS: In these studies, we tested the hypothesis that increased lipid intake would exacerbate the severity of nutritional steatohepatitis.
METHODS: C57Bl/6J mice were fed methionine-and-choline deficient (MCD) diets containing 20% (high) or 5% (low) fat by weight for 3 weeks and compared to lipid-matched controls.
RESULTS: MCD feeding increased serum ALT levels and induced hepatic steatosis, lobular inflammation and ballooning degeneration of hepatocytes, irrespective of dietary fat content. Hepatic triglyceride accumulation was similar between high and low-fat MCD-fed mice, but lipoperoxide levels were approximately 3-fold higher in the high-fat MCD-fed animals. Serum adiponectin levels increased in MCD-fed mice, although to a lesser extent in high-fat fed animals. AMPK phosphorylation was correspondingly increased in muscle of MCD-fed mice, but hepatic AMPK phosphorylation decreased, and there was little evidence of PPAR alpha activation, suggesting impaired adiponectin action in the livers of MCD-fed animals. Hepatocyte PPAR gamma mRNA levels increased in MCD-fed mice, and were associated with increased aP2 expression, indicating adipogenic transformation of hepatocytes.
CONCLUSIONS: Increased dietary lipid intake did not alter steatohepatitis severity in MCD-fed mice despite increased lipoperoxide accumulation. Instead, steatohepatitis was associated with impaired hepatic adiponectin action, and adipogenic transformation of hepatocytes in both low and high-fat MCD-fed mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534710     DOI: 10.1016/j.jhep.2008.03.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.

Authors:  Samar H Ibrahim; Petra Hirsova; Harmeet Malhi; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2015-12-01       Impact factor: 3.199

3.  Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Gregory J Gores
Journal:  Clin Lipidol       Date:  2010-02-01

Review 4.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

5.  Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.

Authors:  Josef Wanninger; Sabrina Bauer; Kristina Eisinger; Thomas S Weiss; Roland Walter; Claus Hellerbrand; Andreas Schäffler; Akiko Higuchi; Kenneth Walsh; Christa Buechler
Journal:  Mol Cell Endocrinol       Date:  2011-11-18       Impact factor: 4.102

6.  Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Authors:  Jamil A Haque; Ryan S McMahan; Jean S Campbell; Masami Shimizu-Albergine; Angela M Wilson; Dianne Botta; Theo K Bammler; Richard P Beyer; Thomas J Montine; Matthew M Yeh; Terrance J Kavanagh; Nelson Fausto
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

Review 7.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

8.  Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.

Authors:  Xiaoli Pan; Pei Wang; Jinzhuo Luo; Zhijun Wang; Yuhu Song; Jin Ye; Xiaohua Hou
Journal:  Endocrine       Date:  2014-08-20       Impact factor: 3.633

9.  Serum levels of the adipokine FGF21 depend on renal function.

Authors:  Sebastian Stein; Anette Bachmann; Ulrike Lössner; Jürgen Kratzsch; Matthias Blüher; Michael Stumvoll; Mathias Fasshauer
Journal:  Diabetes Care       Date:  2008-10-07       Impact factor: 17.152

10.  A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH.

Authors:  Fusako Takayama; Toru Egashira; Hiromu Kawasaki; Mitsumasa Mankura; Kazuo Nakamoto; Shigeru Okada; Akitane Mori
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.